These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4465958)

  • 21. Comparison of benztropine mesylate and amantadine HCl in neuroleptic-induced extrapyramidal symptoms.
    Stenson RL; Donion PT; Meyer JE
    Compr Psychiatry; 1976; 17(6):763-8. PubMed ID: 791573
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of Dopaflex and Viregyt-K on gait and postural disturbances of operated and non-operated Parkinsonian patients.
    Boczán G; Borus F; Rózsa L
    Ther Hung; 1975; 23(1):17-20. PubMed ID: 1105872
    [No Abstract]   [Full Text] [Related]  

  • 23. [Iron, transferrin, copper and ceruloplasmin of the serum and cerebrospinal fluid in extrapyramidal diseases and primary myopathies. Study in basic conditions and in Parkinsonism after treatment with dopaminergic agents (L-dopa, L-dopa + RO 4-4602, amantadine)].
    Campanella G; Carrieri P; Romito D; Pasqual-Marsettin E
    Acta Neurol (Napoli); 1973; 28(1):1-34. PubMed ID: 4704396
    [No Abstract]   [Full Text] [Related]  

  • 24. [Extrapyramidal reactions and neuroleptic malignant syndrome].
    Gómez EA
    Acta Psiquiatr Psicol Am Lat; 1984 Dec; 30(4):281-6. PubMed ID: 6535382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amantadine hydrochloride in treatment of Parkinsonism.
    Nagaswami S; Nagaswami R
    Dis Nerv Syst; 1973; 34(5):253-8. PubMed ID: 4782280
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of parkinsonism with viregyt (amantadine)].
    Pryszmont M; Jankowicz E; Eljasz L; Slizewski M; Wiśniewska Z
    Wiad Lek; 1974 Aug; 27(15):1371-5. PubMed ID: 4418066
    [No Abstract]   [Full Text] [Related]  

  • 27. Amantadine in extrapyramidal syndromes induced by neuroleptic drugs.
    Dencker SJ; Lindberg D; Malm U
    Nord Psykiatr Tidsskr; 1973; 27(1):31-4. PubMed ID: 4687749
    [No Abstract]   [Full Text] [Related]  

  • 28. Extrapyramidal symptoms in Wilson's disease are associated with olfactory dysfunction.
    Mueller A; Reuner U; Landis B; Kitzler H; Reichmann H; Hummel T
    Mov Disord; 2006 Sep; 21(9):1311-6. PubMed ID: 16763975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of amantadine, orphenadrine, and placebo in the control of phenothiazine-induced Parkinsonism.
    Mindham RH; Gaind R; Anstee BH; Rimmer L
    Psychol Med; 1972 Nov; 2(4):406-13. PubMed ID: 4571143
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical study of amantadine in extrapyramidal syndromes caused by neuroleptics].
    Nardini M; Fanali A; Sorgonà F; Vergnano M; Fieschi G
    Minerva Med; 1971 Oct; 62(82):4020-3. PubMed ID: 5125070
    [No Abstract]   [Full Text] [Related]  

  • 31. Amantadine.
    Parkes D
    Adv Drug Res; 1974; 8():11-81. PubMed ID: 4219097
    [No Abstract]   [Full Text] [Related]  

  • 32. [Syndrome involving the extrapyramidal motor systems and their drug treatment].
    Soyka D
    Fortschr Med; 1974 Aug; 92(22):906-9. PubMed ID: 4153689
    [No Abstract]   [Full Text] [Related]  

  • 33. Neuroleptic drug exposure and treatment of parkinsonism in the elderly: a case-control study.
    Avorn J; Bohn RL; Mogun H; Gurwitz JH; Monane M; Everitt D; Walker A
    Am J Med; 1995 Jul; 99(1):48-54. PubMed ID: 7598142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Modern antiparkinsonics (L-dopa and amantadine) and presentday psychiatry (author's transl)].
    Dolezalová B; Vacek J
    Cesk Psychiatr; 1976 Dec; 72(6):403-7. PubMed ID: 1000706
    [No Abstract]   [Full Text] [Related]  

  • 35. On the synchronizing effect of amantadine-1-hydrochlorid (Symmetrel) on pathological EEG-activity.
    Vardi J; Streifler M
    J Neural Transm; 1975; 37(1):73-80. PubMed ID: 1159416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amantadine reduces levodopa-induced dyskinesias in parkinsonian monkeys.
    Blanchet PJ; Konitsiotis S; Chase TN
    Mov Disord; 1998 Sep; 13(5):798-802. PubMed ID: 9756148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Current treatment of the Parkinsonian syndrome].
    Voiculescu V
    Neurol Psihiatr Neurochir; 1973; 18(6):519-23. PubMed ID: 4790485
    [No Abstract]   [Full Text] [Related]  

  • 38. [Use of the Soviet preparation midantan in the treatment of the Parkinsonian syndrome].
    Balunov OA; Bazhin EF; Morozova ES; Fedotenkova TN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1974; 74(8):1178-81. PubMed ID: 4417237
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of Parkinson's syndrome].
    Fortschr Med; 1982 Jun; 100(24):1172. PubMed ID: 7106681
    [No Abstract]   [Full Text] [Related]  

  • 40. [Experimental design of a pilot study on amantadine in the extrapyramidal syndrome induced by neuroleptic drugs].
    Ferrari P; Robotti E; Nardini M
    Boll Chim Farm; 1972 Oct; 111(10):610-5. PubMed ID: 4566407
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.